Cargando…
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling
We provide causal evidence that regulation induced product shocks significantly impact aggregate demand and firm performance in pharmaceutical markets. Event study results suggest an average loss between $569 million and $882 million. Affected products lose, on average, $186 million over their remai...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486863/ https://www.ncbi.nlm.nih.gov/pubmed/32952226 http://dx.doi.org/10.1016/j.respol.2020.104126 |